GeoWealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Buy
17,850
+7,195
+68% +$419K 0.04% 263
2025
Q4
$575K Sell
10,655
-239
-2% -$11.5K 0.02% 406
2025
Q3
$491K Sell
10,894
-931
-8% -$43.5K 0.02% 455
2025
Q2
$547K Buy
11,825
+208
+2% +$10.2K 0.02% 387
2025
Q1
$709K Sell
11,617
-2,150
-16% -$125K 0.03% 349
2024
Q4
$779K Sell
13,767
-98
-0.7% -$5.48K 0.03% 361
2024
Q3
$717K Buy
13,865
+2,468
+22% +$116K 0.03% 385
2024
Q2
$473K Sell
11,397
-6,925
-38% -$310K 0.02% 446
2024
Q1
$994K Buy
18,322
+7,826
+75% +$399K 0.04% 294
2023
Q4
$539K Buy
10,496
+8,505
+427% +$446K 0.04% 319
2023
Q3
$115K Buy
1,991
+389
+24% +$23.8K 0.01% 322
2023
Q2
$103K Buy
1,602
+41
+3% +$2.75K 0.01% 286
2023
Q1
$108K Sell
1,561
-35
-2% -$2.47K 0.01% 237
2022
Q4
$114K Sell
1,596
-69
-4% -$5.2K 0.01% 269
2022
Q3
$118K Buy
+1,665
New +$121K 0.01% 265
2021
Q3
Sell
-1,101
Closed -$74K 394
2021
Q2
$74K Buy
+1,101
New +$71.8K 0.01% 224
2019
Q4
Sell
-5,109
Closed -$259K 113
2019
Q3
$259K Buy
+5,109
New +$240K 0.06% 170

Other funds holding BMY

GeoWealth Management's BMY Position: Q1 2026 in Review

GeoWealth Management increased its Bristol-Myers Squibb (BMY) stake by 68% in Q1 2026, buying an estimated $419K and bringing the position to 17,850 shares worth $1.08M. The position accounts for 0.04% of the portfolio, ranked #263.

GeoWealth Management first reported a position in BMY in Q3 2019 and has held it in 17 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • GeoWealth Management held 17,850 shares of Bristol-Myers Squibb worth $1.08M as of Q1 2026.
  • GeoWealth Management bought 7,195 Bristol-Myers Squibb shares in Q1 2026, an estimated $419K.
  • Bristol-Myers Squibb made up 0.04% of GeoWealth Management's portfolio in Q1 2026, its #263 holding.
  • GeoWealth Management first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 17 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on GeoWealth Management's 13F filing for Q1 2026, filed 13 May 2026.